about
Neto1 is a novel CUB-domain NMDA receptor-interacting protein required for synaptic plasticity and learningMutation I810N in the alpha3 isoform of Na+,K+-ATPase causes impairments in the sodium pump and hyperexcitability in the CNS.PTG depletion removes Lafora bodies and rescues the fatal epilepsy of Lafora diseaseGeneralized myoclonic epilepsy with photosensitivity in juvenile dogs caused by a defective DIRAS family GTPase 1Nonconvulsive seizures in the pediatric intensive care unit: etiology, EEG, and brain imaging findings.Succinic semialdehyde dehydrogenase deficiency: lessons from mice and menThe significance of frontal intermittent rhythmic delta activity in children.Evidence that clozapine directly interacts on the GABAB receptor.Anticonvulsant properties of acetone, a brain ketone elevated by the ketogenic diet.Interactions of clobazam with conventional antiepileptics in children.LIMK1 regulates long-term memory and synaptic plasticity via the transcriptional factor CREB.Circadian distribution of generalized tonic-clonic seizures associated with murine succinic semialdehyde dehydrogenase deficiency, a disorder of GABA metabolism.Arrhythmia and sudden death associated with elevated cardiac chloride channel activityCircadian profiles of focal epileptic seizures: a need for reappraisal.Acute and chronic pharmacological models of generalized absence seizures.Systemic availability of guanidinoacetate affects GABAA receptor function and seizure threshold in GAMT deficient mice.Hormonal regulation of atypical absence seizures.The GIRK2 subunit is involved in IS-like seizures induced by GABA(B) receptor agonists.Diagnostic Utility of Wireless Video-Electroencephalography in Unsedated Dogs.Neuroligin 3 R451C mutation alters electroencephalography spectral activity in an animal model of autism spectrum disorders.Paroxysmal alpha activity in Rett syndrome: a case report.Disruption of ClC-2 expression is associated with progressive neurodegeneration in aging mice.The circuitry of atypical absence seizures in GABA(B)R1a transgenic mice.Gamma-hydroxybutyric acid-induced absence seizures in GluR2 null mutant mice.Brain sterols in the AY-9944 rat model of atypical absence seizures.Environmental enrichment improves behavioral outcome in the AY-9944 model of childhood atypical absence epilepsy.Reactive EEG patterns in pediatric coma.Laforin preferentially binds the neurotoxic starch-like polyglucosans, which form in its absence in progressive myoclonus epilepsy.Lovastatin exacerbates atypical absence seizures with only minimal effects on brain sterols.Learning and memory impairment in rats with chronic atypical absence seizures.Absence seizures in succinic semialdehyde dehydrogenase deficient mice: a model of juvenile absence epilepsy.Monoamine variability in the chronic model of atypical absence seizures.Serotonin depletion attenuates AY-9944-mediated atypical absence seizures.Absence Seizures as a Feature of Juvenile Myoclonic Epilepsy in Rhodesian Ridgeback Dogs.Infantile spasms in down syndrome: Rescue by knockdown of the GIRK2 channel.Absence seizures with myoclonic features in a juvenile Chihuahua dog.Transgenic mice over-expressing GABA(B)R1a receptors acquire an atypical absence epilepsy-like phenotype.Chronobiometry of behavioral activity in the Ts65Dn model of Down syndrome.Predictive value of clinical and EEG features in the diagnosis of stroke and hypoxic ischemic encephalopathy in neonates with seizures.Type I diabetes and multiple sclerosis patients target islet plus central nervous system autoantigens; nonimmunized nonobese diabetic mice can develop autoimmune encephalitis.
P50
Q21145835-901000FB-A486-46C9-846B-ED55E6E279C8Q24649570-5FAC94F0-B12D-4E04-8381-0ECCD4BF1166Q28477920-C23E41A5-3133-41D9-86D0-6DCE7C660D2DQ30841672-CFB6A5AE-72C0-42E2-BCA8-C6B26A307CD9Q31061397-1AC40417-7CA3-4D13-96A8-D44F5972F8C0Q33403217-3354A988-EFFE-4A0E-A445-82101F72BDE9Q33741277-4135B20C-46E0-44A5-A61B-C593BE7CEFE3Q34200230-EF34AB04-11E1-40FF-B153-E194E20419EAQ34218736-BC5E7849-9D16-4B96-AA49-668455733CACQ34424215-F0BEC5F2-C1C1-4AEC-AE89-8F39627B52DAQ35214701-DDF0EE2C-8F2C-4D94-81F1-4C4EAD60007EQ36953244-07EC49C9-E39C-4694-84D2-28BCD68824FDQ37294837-C7020023-8E4F-4F5C-8180-37622AE1D2F8Q38005790-A18CDC53-47F6-4139-A6CB-374854D8FE02Q38581711-A091EB67-44D5-4239-AEF6-1D4008D20DA9Q39981198-F6BC1D82-66FF-4C77-8D77-7B14D8247C76Q40584096-B5A35CA7-3E81-40BA-8D44-BEF814F1FF93Q40880509-E3F08B0F-7D54-4EFF-A002-A32C470708B1Q41074822-4DDCDA47-0D20-40A7-9F58-437B05BE0E6DQ41850563-C7768E79-8BA3-4742-B7DA-818C844EC2D0Q41929579-DD56AD60-9B76-403C-B6A8-B7C5510CB7EBQ43179958-ED3C36E5-E94A-4164-AE19-6F69AEE53396Q43295603-B6CAB24C-4488-4CAF-9163-C60EF1C723B0Q43562304-2CE5526B-F57D-4195-BF71-9B83E3BD2FA5Q43906076-45161E02-D427-4490-9653-942DE27501A7Q44196994-049C9370-7B4F-4C46-811F-35B921354D4CQ44578973-29D6F40B-2380-44F0-B180-9FB3E0100859Q44854724-13457876-D424-4AE9-88EA-C40E5510E5E3Q45020510-9E4252B4-7AFE-464C-8B63-AE93341B36A1Q45142310-551B2D38-9E24-469F-B35E-87AC442889C9Q45175597-560E5544-F75B-4867-AE91-156A873D46ABQ46215534-46694188-AF00-4F64-B8B6-8888CF4EFB3DQ46962018-1415DFC5-7AAC-4D2C-8BFB-CE20009C9EE8Q47568787-420ACDBA-5A64-4309-9E55-8D6B19D49422Q47972710-03277571-3FB4-4A33-8226-9F9A876D0731Q48192985-DF8D2E8B-117D-4BAC-B9A3-F38A7F77EAE1Q48239976-64334D72-CE48-44BA-8984-0B576787BCC6Q48347577-62620BC2-99DA-442D-8D33-B25D57A02DA0Q48595447-33522721-965D-4AA7-9509-67A11A4FE880Q49071770-407F02B9-3D70-464A-8C14-21BE3D8D9C50
P50
description
researcher ORCID ID = 0000-0003-1445-3521
@en
wetenschapper
@nl
name
Miguel A Cortez
@ast
Miguel A Cortez
@en
Miguel A Cortez
@es
Miguel A Cortez
@nl
type
label
Miguel A Cortez
@ast
Miguel A Cortez
@en
Miguel A Cortez
@es
Miguel A Cortez
@nl
prefLabel
Miguel A Cortez
@ast
Miguel A Cortez
@en
Miguel A Cortez
@es
Miguel A Cortez
@nl
P106
P1153
7005014445
P21
P31
P496
0000-0003-1445-3521